Top News
Racial Disparities Persist in Ovarian Cancer Treatment
Overall Breast Cancer Incidence Decreased From 1999 to 2018
Daratumumab Dosing Frequency and Cost of Care in Multiple Myeloma
Analysis Demonstrates Predictive Capacity of 4 Staging Systems for Cutaneous Squamous Cell Carcinoma
White House Launches Website for Free Home COVID-19 Tests a Day Ahead of Schedule
NCCN Endorses Full COVID-19 Vaccination for Cancer Patients
Cancer Patients Have Higher Risk of Missed Payments, Collections, and Repossessions
Method Improves Risk Assessment for Lung Cancer Screening
Polygenic Score May Identify Kids, AYAs With AML Who Need Augmented Therapy
Sitting, Inactivity Increase Death Risk Among Cancer Survivors
Dense Breasts, High BMI May Interact to Up Breast Cancer Risk
EDITORIAL ADVISORY BOARD
E. David Crawford, MD
Jeffrey M. Farma, MD
Featured
-
Physicians Must Help Patients Evaluate Risk vs Benefit
Physicians can help patients make medical decisions, such as whether to get a COVID-19 vaccination, by asking them to articulate their beliefs about risks and benefits. -
NCCN Endorses Full COVID-19 Vaccination for Cancer Patients
The NCCN Advisory Committee offers guidance on the timing of COVID-19 vaccination in cancer patients. -
Phase 3 Studies Herald More Options for Metastatic Breast Cancer
Dr Alan Lyss details the results and clinical implications of the EMERALD, PHOEBE, and DESTINY-Breast03 trials. -
Giving Immune Checkpoint Inhibitors Within 90 Days of Radiation Appears Safe
Rates of adverse events were generally similar between patients who did and did not receive radiation. -
Metabolomic Analysis Can Detect Cancer Before Conventional Imaging
The method identified solid tumors in patients with nonspecific symptoms. -
Aesthetic Treatments for Post-Cancer Care
Cancer treatments may negatively affect the skin in a variety of ways, but aesthetic treatments can improve the skin’s appearance and patients’ quality of life. -
Black Prostate Cancer Patients Fare Better With RT, Despite More Aggressive Disease
Black race was associated with lower rates of biochemical relapse, distant metastases, and prostate cancer-specific mortality. -
COVID-19 and Lung Cancer: What We Know and Don’t Know
Researchers have summarized what is known about COVID-19 in the context of lung cancer and highlighted areas where more research is needed. -
Managing Cancer-Related Pain in Patients With Opioid Use Disorder
The patient’s prognosis should inform the decision to add full-agonist opioids to treatment.
More Features
Cardiovascular Disease in Breast Cancer: Better Preventative Strategies Needed
Cardiovascular disease remains a leading cause of death among breast cancer survivors.
Cancer Patients May Have Double the Risk of Breakthrough Infection After COVID-19 Vaccination
A meta-analysis suggests that patients with cancer may be twice as likely as non-cancer patients to have a breakthrough infection after being fully vaccinated.
MIBC Tumor Subtypes May Guide Neoadjuvant Chemotherapy Use
Neoadjuvant chemotherapy response rates differed among patients with genomically unstable bladder tumors, urothelial-like bladder tumors, and basal/squamous subtypes.
Do Antibiotics Affect Outcomes of Immunotherapy in Lung Cancer?
A meta-analysis revealed inferior responses, progression-free survival, and overall survival in patients exposed to antibiotics.
Controversy Prompts Another Update to NCCN Guidelines for Prostate Cancer
After physicians voiced concerns about an active surveillance recommendation, the NCCN panel revised the guidelines.
- Loading...
Loading...
Loading... 
Loading...